FOXO Technologies Inc. (FOXO) - Net Assets
Based on the latest financial reports, FOXO Technologies Inc. (FOXO) has net assets worth $20.14 Million USD as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($52.09 Million) and total liabilities ($31.96 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Read FOXO Technologies Inc. total liabilities for a breakdown of total debt and financial obligations.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $20.14 Million |
| % of Total Assets | 38.65% |
| Annual Growth Rate | -11.82% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 39.51 |
FOXO Technologies Inc. - Net Assets Trend (2020–2024)
This chart illustrates how FOXO Technologies Inc.'s net assets have evolved over time, based on quarterly financial data. Also explore FOXO Technologies Inc. balance sheet assets for the complete picture of this company's asset base.
Annual Net Assets for FOXO Technologies Inc. (2020–2024)
The table below shows the annual net assets of FOXO Technologies Inc. from 2020 to 2024. For live valuation and market cap data, see FOXO Technologies Inc. (FOXO) total market value.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $5.27 Million | +137.39% |
| 2023-12-31 | $-14.10 Million | -310.20% |
| 2022-12-31 | $6.71 Million | +126.60% |
| 2021-12-31 | $-25.22 Million | -389.22% |
| 2020-12-31 | $8.72 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to FOXO Technologies Inc.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 17705306700.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $2.36K | 0.04% |
| Other Components | $195.86 Million | 3679.03% |
| Total Equity | $5.32 Million | 100.00% |
FOXO Technologies Inc. Competitors by Market Cap
The table below lists competitors of FOXO Technologies Inc. ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
International Zeolite Corp
V:IZ
|
$306.77K |
|
SkinBioTherapeutics PLC
LSE:SBTX
|
$307.45K |
|
Wyld Networks AB
ST:WYLD
|
$309.24K |
|
GETT Gold Inc
V:GETT
|
$309.68K |
|
Sanco Industries Limited
NSE:SANCO
|
$303.62K |
|
Arecor Therapeutics PLC
LSE:AREC
|
$303.20K |
|
Capital Metals PLC
LSE:CMET
|
$302.20K |
|
Petro Matad Ltd
LSE:MATD
|
$302.12K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in FOXO Technologies Inc.'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -14,100,000 to 5,323,752, a change of 19,423,752.
- Net loss of 12,406,389 reduced equity.
- New share issuances of 89,925 increased equity.
- Other factors increased equity by 31,740,216.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-12.41 Million | -233.04% |
| Share Issuances | $89.92K | +1.69% |
| Other Changes | $31.74 Million | +596.2% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares FOXO Technologies Inc.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.00x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-12-31 | $43.60 | $0.00 | x |
| 2021-12-31 | $-43.33 | $0.00 | x |
| 2022-12-31 | $5.92 | $0.00 | x |
| 2023-12-31 | $-3.34 | $0.00 | x |
| 2024-12-31 | $0.36 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently FOXO Technologies Inc. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -233.04%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -306.21%
- • Asset Turnover: 0.10x
- • Equity Multiplier: 7.83x
- Recent ROE (-233.04%) is above the historical average (-350.46%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | -99.23% | -13734.92% | 0.01x | 1.08x | $-9.53 Million |
| 2021 | 0.00% | -32073.33% | 0.00x | 0.00x | $-35.97 Million |
| 2022 | -1420.02% | -18640.90% | 0.01x | 5.28x | $-95.93 Million |
| 2023 | 0.00% | -18205.21% | 0.20x | 0.00x | $-25.04 Million |
| 2024 | -233.04% | -306.21% | 0.10x | 7.83x | $-12.94 Million |
Industry Comparison
This section compares FOXO Technologies Inc.'s net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $517,935,083
- Average return on equity (ROE) among peers: -17.26%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| FOXO Technologies Inc. (FOXO) | $20.14 Million | -99.23% | 1.59x | $306.27K |
| Aclarion Inc (ACON) | $-5.73 Million | 0.00% | 0.00x | $1.99 Million |
| American Well Corp (AMWL) | $1.08 Billion | -24.95% | 0.12x | $90.87 Million |
| Heartbeam Inc (BEAT) | $63.68 Million | -15.38% | 0.96x | $30.37 Million |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG) | $-3.06 Million | 0.00% | 0.00x | $6.51 Million |
| BrightSpring Health Services, Inc. Common Stock (BTSG) | $1.65 Billion | -1.09% | 2.59x | $8.82 Billion |
| Carlsmed, Inc. Common Stock (CARL) | $98.87 Million | -30.56% | 0.32x | $253.42 Million |
| CareCloud Inc. (CCLD) | $118.50K | -150.21% | 47.72x | $117.28 Million |
| Certara Inc (CERT) | $492.77 Million | -6.75% | 1.13x | $983.48 Million |
| CareMax Inc (CMAX) | $6.73 Million | 88.33% | 4.72x | $381.50 |
| Claritev Corporation (CTEV) | $1.79 Billion | -32.00% | 3.12x | $277.75 Million |
About FOXO Technologies Inc.
FOXO Technologies Inc. operates as a healthcare services and technology company in the United States. The company operates through two segments: Healthcare and Labs and Life. The company offers behavioural health; ancillary, including laboratory, radiology, respiratory, and pharmacy; insurance; and other services. The company applies automated machine learning and artificial intelligence (AI) tec… Read more